Correlation Between Sellas Life and I Mab

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sellas Life and I Mab at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sellas Life and I Mab into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sellas Life Sciences and I Mab, you can compare the effects of market volatilities on Sellas Life and I Mab and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sellas Life with a short position of I Mab. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sellas Life and I Mab.

Diversification Opportunities for Sellas Life and I Mab

0.34
  Correlation Coefficient

Weak diversification

The 3 months correlation between Sellas and IMAB is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Sellas Life Sciences and I Mab in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on I Mab and Sellas Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sellas Life Sciences are associated (or correlated) with I Mab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of I Mab has no effect on the direction of Sellas Life i.e., Sellas Life and I Mab go up and down completely randomly.

Pair Corralation between Sellas Life and I Mab

Considering the 90-day investment horizon Sellas Life is expected to generate 4.26 times less return on investment than I Mab. But when comparing it to its historical volatility, Sellas Life Sciences is 1.1 times less risky than I Mab. It trades about 0.06 of its potential returns per unit of risk. I Mab is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest  88.00  in I Mab on October 28, 2024 and sell it today you would earn a total of  20.00  from holding I Mab or generate 22.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Sellas Life Sciences  vs.  I Mab

 Performance 
       Timeline  
Sellas Life Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sellas Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
I Mab 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days I Mab has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, I Mab is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Sellas Life and I Mab Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sellas Life and I Mab

The main advantage of trading using opposite Sellas Life and I Mab positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sellas Life position performs unexpectedly, I Mab can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in I Mab will offset losses from the drop in I Mab's long position.
The idea behind Sellas Life Sciences and I Mab pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Transaction History
View history of all your transactions and understand their impact on performance